EDAP TMS S.A.
Research EDAP TMS S.A. (EDAP) on Bullrun: market cap USD 180.29M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerEDAP
- ExchangeNASDAQ
- CountryFrance
- SectorHealthcare
- IndustryMedical Distribution
- CurrencyUSD
- Market capUSD 180.29M
- Financial periodQ1 2026
- RevenueUSD 74.07M
- Net income-USD 9.08M
- Free cash flow-USD 3.90M
- Gross margin43.4%
Valuation Snapshot
latest market cap is USD 180.29M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 70.53M | -USD 29.25M | -USD 22.17M | 42.5% | -0.78 | USD 20.45M | USD 18.02M | USD 19.41M |
| FY2024 | USD 69.40M | -USD 20.58M | -USD 16.34M | 41.4% | -0.55 | USD 31.00M | USD 4.75M | USD 42.49M |
| FY2023 | n/a | n/a | n/a | n/a | -1.01 | USD 43.47M | USD 8.42M | USD 56.92M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-06-18 | USD 180.29M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 123.32M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 82.64M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 194.98M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 385.31M | 96.9 | n/a | n/a |
| 2021 | 2021-12-31 | USD 200.46M | 299.5 | n/a | n/a |
About EDAP TMS S.A.
EDAP TMS S.A., a medical technology company, engages in the development, manufacturing, marketing, and sale of non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution segments.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is EDAP TMS S.A.'s market cap?
EDAP TMS S.A.'s market capitalization is USD 180.29M.
What does EDAP TMS S.A. do?
EDAP TMS S.A., a medical technology company, engages in the development, manufacturing, marketing, and sale of non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution segments. The HIFU segment develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications.